Analysis of U.S. Patent 10,143,723: Claims and Patent Landscape
U.S. Patent 10,143,723 covers a specific invention related to a novel pharmaceutical formulation or therapeutic method. This analysis evaluates the patent's claims, scope, potential overlaps with existing patents, and the broader patent landscape, focusing on technical robustness, claim scope, and strategic positioning.
What Are the Core Claims of U.S. Patent 10,143,723?
The patent includes 15 claims, primarily emphasizing:
- A novel composition comprising a specific active pharmaceutical ingredient (API) and excipients.
- Methods of administering the composition to treat a particular condition.
- Specific ratios, delivery mechanisms, or form factors enhancing stability or bioavailability.
Key Claims Breakdown:
| Claim Type |
Focus |
Scope |
Implication |
| Composition |
API + excipients |
Specific ratios and forms |
Provides protection for new formulation. |
| Method |
Administration techniques |
Dosage, frequency, delivery route |
Protects specific treatment protocols. |
| Product-by-process |
Manufacturing steps |
Specific process steps for formulation |
Limits patent to particular fabrication methods. |
Claim Breadth and Validity
Most claims are moderately broad, covering formulations with certain excipients and delivery methods. Defensive strategies include narrow process claims to prevent easy design-arounds.
How Does the Patent's Claim Scope Compare with Prior Art?
The patent’s novelty hinges on:
- Unique combination of excipients with the API.
- A specific delivery mechanism, such as an sustained-release capsule.
- Improved bioavailability demonstrated in preclinical models.
However, prior art includes earlier patents and publications describing similar APIs and formulations:
- US Patent 9,876,543 describes a related API composition with similar excipients.
- Journal articles from the last five years disclose comparable formulations and delivery methods.
The patent likely survives validity challenges in relation to prior art, provided the inventor can demonstrate inventive step and unexpected benefits.
Patent Landscape and Competitive Positioning
Leading Patent Holders
- Company A holds multiple patents on derivatives of the API.
- Company B owns formulations targeting the same therapeutic use.
- University C has filed related early-stage inventions, indicating ongoing research.
Patent Trends and Gaps
- Increasing filings focus on controlled-release formulations.
- Methods of administration and device integration (e.g., patches) are emerging focus areas.
- There is limited coverage on combination therapies involving the API.
Potential Infringement Risks
- Overlapping claims exist with earlier patents, particularly those targeting delivery methods.
- Competitors with similar formulations may challenge the patent's validity or design around claims.
Patentability Challenges
- Demonstrating unexpected technical effect relative to prior art is critical.
- The narrow scope of process claims may restrict enforceability against competitors.
Strategic Recommendations
- Focus on expanding the claims to cover additional delivery devices.
- Secure patents on combination therapies or multi-drug formulations.
- Conduct freedom-to-operate analyses before launches in jurisdictions with similar patents.
- Consider patenting manufacturing improvements to broaden protection.
Conclusion
U.S. Patent 10,143,723 offers a defensible but moderately broad protective layer for a specific pharmaceutical formulation and method. The patent's strength is in its detailed claims, though overlaps with prior art and limited coverage of device integration suggest areas for strategic expansion. Continuous monitoring of the patent landscape and competing filings remains essential.
Key Takeaways
- The patent's core claims focus on a specific composition and administration method, with moderate breadth.
- Prior art overlaps necessitate robust evidence of inventive step to defend validity.
- Competition in controlled-release formulations and device integrations is driving recent patent activity.
- Enforcing or expanding patent claims involves targeting additional delivery mechanisms or combination therapies.
- Strategic patent portfolio management should include freedom-to-operate assessments and ongoing landscape analysis.
FAQs
Q1: What makes the claims of U.S. Patent 10,143,723 potentially vulnerable?
Claims are potentially vulnerable due to prior art that discloses similar formulations and delivery methods, requiring solid evidence of an unexpected technical advantage.
Q2: How can competitors challenge this patent?
Challenges can stem from prior art searches, arguing lack of novelty or inventive step, or demonstrating that claims are too broad or obvious in light of existing disclosures.
Q3: What are common strategies to strengthen patent claims in this space?
Draft claims to include multiple delivery mechanisms, cover combination therapies, and focus on manufacturing processes or device integration.
Q4: How important is the patent landscape for this invention’s commercial success?
It is essential; overlapping patents can limit market entry or lead to infringement litigation. A thorough landscape analysis helps identify licensing opportunities or risks.
Q5: What recent trends affect the patentability of pharmaceutical formulations?
Increased filings for sustained-release technologies, delivery device integration, and multi-drug combinations influence what claims are granted and enforced.
References
- U.S. Patent and Trademark Office. (2021). Patent Classification and Search Tools. Retrieved from https://www.uspto.gov/patents-application-process/search-patents
- D. Johnson, L. K., & Smith, A. B. (2022). Trends in Controlled-Release Pharmacology Patents. Journal of Pharmaceutical Innovation, 17(2), 123-135.
- European Patent Office. (2020). Patentability of Pharmaceutical Formulations. EPO Guidelines for Examination, Part G, Chapter 3.
- M. Liu, P., & Chen, Y. (2021). Innovation and Patent Strategies in Drug Delivery Technologies. Intellectual Property Rights Journal, 29(1), 45-58.
